Eledon Pharmaceuticals, Inc.
ELDN
$2.82
-$0.11-3.75%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 88.76M | 111.09M | 133.34M | 93.40M | 107.57M |
| Total Receivables | 427.00K | 583.00K | 514.00K | 753.00K | 705.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.53M | 1.89M | 1.83M | 2.13M | 3.12M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 382.00K | 9.00K | 11.00K | 14.00K | 10.00K |
| Total Current Assets | 93.09M | 113.57M | 135.69M | 96.30M | 111.40M |
|
|
|||||
| Total Current Assets | 93.09M | 113.57M | 135.69M | 96.30M | 111.40M |
| Net Property, Plant & Equipment | 445.00K | 530.00K | 613.00K | 694.00K | 773.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 32.39M | 32.39M | 32.39M | 32.39M | 32.39M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 172.00K | 177.00K | 322.00K | 476.00K | 346.00K |
| Total Assets | 126.09M | 146.67M | 169.01M | 129.86M | 144.91M |
|
|
|||||
| Total Accounts Payable | 3.21M | 6.59M | 3.63M | 4.63M | 5.83M |
| Total Accrued Expenses | 8.19M | 6.50M | 14.36M | 9.32M | 7.55M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 381.00K | 369.00K | 358.00K | 346.00K | 336.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 11.79M | 13.46M | 18.34M | 14.30M | 13.72M |
|
|
|||||
| Total Current Liabilities | 11.79M | 13.46M | 18.34M | 14.30M | 13.72M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 86.00K | 186.00K | 283.00K | 376.00K | 467.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 42.19M | 32.57M | 13.60M | 24.13M | 24.70M |
| Total Liabilities | 54.06M | 46.21M | 32.23M | 38.80M | 38.88M |
|
|
|||||
| Common Stock & APIC | 544.00M | 540.76M | 537.96M | 481.80M | 479.37M |
| Retained Earnings | -471.86M | -440.23M | -401.20M | -390.76M | -373.30M |
| Treasury Stock & Other | -114.00K | -72.00K | 24.00K | 9.00K | -48.00K |
| Total Common Equity | 72.03M | 100.46M | 136.78M | 91.05M | 106.03M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 72.03M | 100.46M | 136.78M | 91.05M | 106.03M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 72.03M | 100.46M | 136.78M | 91.05M | 106.03M |
|
|
|||||